1. Home
  2. SCYX vs NCEW Comparison

SCYX vs NCEW Comparison

Compare SCYX & NCEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • NCEW
  • Stock Information
  • Founded
  • SCYX 1999
  • NCEW 2002
  • Country
  • SCYX United States
  • NCEW Hong Kong
  • Employees
  • SCYX N/A
  • NCEW N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • NCEW
  • Sector
  • SCYX Health Care
  • NCEW
  • Exchange
  • SCYX Nasdaq
  • NCEW NYSE
  • Market Cap
  • SCYX 28.5M
  • NCEW 25.4M
  • IPO Year
  • SCYX 2014
  • NCEW 2024
  • Fundamental
  • Price
  • SCYX $0.70
  • NCEW $0.76
  • Analyst Decision
  • SCYX
  • NCEW
  • Analyst Count
  • SCYX 0
  • NCEW 0
  • Target Price
  • SCYX N/A
  • NCEW N/A
  • AVG Volume (30 Days)
  • SCYX 187.5K
  • NCEW 93.8K
  • Earning Date
  • SCYX 08-11-2025
  • NCEW 08-15-2025
  • Dividend Yield
  • SCYX N/A
  • NCEW N/A
  • EPS Growth
  • SCYX N/A
  • NCEW N/A
  • EPS
  • SCYX N/A
  • NCEW 0.01
  • Revenue
  • SCYX $2,630,000.00
  • NCEW $52,176,109.00
  • Revenue This Year
  • SCYX $410.22
  • NCEW N/A
  • Revenue Next Year
  • SCYX $248.83
  • NCEW N/A
  • P/E Ratio
  • SCYX N/A
  • NCEW $70.26
  • Revenue Growth
  • SCYX N/A
  • NCEW 44.64
  • 52 Week Low
  • SCYX $0.66
  • NCEW $0.75
  • 52 Week High
  • SCYX $2.21
  • NCEW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 41.70
  • NCEW N/A
  • Support Level
  • SCYX $0.67
  • NCEW N/A
  • Resistance Level
  • SCYX $0.74
  • NCEW N/A
  • Average True Range (ATR)
  • SCYX 0.04
  • NCEW 0.00
  • MACD
  • SCYX 0.00
  • NCEW 0.00
  • Stochastic Oscillator
  • SCYX 10.15
  • NCEW 0.00

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About NCEW NEW CENTURY LOGISTICS (BVI) LIMITED

New Century Logistics (BVI) Ltd is a well-established freight forwarding service provider based in Hong Kong. The company provides air and ocean export and import freight forwarding services ranging from the sale of cargo space, cargo pick up, off-airport air cargo security screening, palletization, preparation of shipping documentation, and arrangement of customs clearance to cargo handling at ports. It provides a full range of logistics services by providing to its customers with a robust international network that strategically supports the movement of its customers' goods. Includes various logistic like New Century Logistics Company Limited, GLF Cargo Services Limited, Win-Tec Transportation Company Limited.

Share on Social Networks: